1-7 of 7
Sheng-ben Liang
Close
Sort by
Journal Articles

Pre-Clinical Evaluation of a Small Molecule Inhibitor of CDK1 as Potential Therapy for MYC Expressing Mutiple Myeloma Tumors

Seda Zeng, Zhi Hua Li, MD, Marta Chesi, Chungyee Leung-Hagesteijn, MSc, Sheng-ben Liang, PhD, P. Leif Bergsagel, MD, Suzanne Trudel, MD
Journal: Blood
Blood (2008) 112 (11): 3667.
https://doi.org/10.1182/blood.V112.11.3667.3667
Published: 2008
Journal Articles

Cyproheptadine displays preclinical activity in myeloma and leukemia

Xinliang Mao, Sheng-ben Liang, Rose Hurren, Marcela Gronda, Sue Chow, G. Wei Xu, Xiaoming Wang, Reza Beheshti Zavareh, Nazir Jamal, Hans Messner, David W. Hedley, Alessandro Datti, Jeff L. Wrana, Yuanxiao Zhu, Chang-xin Shi, Kyle Lee, Rodger Tiedemann, Suzanne Trudel, A. Keith Stewart, Aaron D. Schimmer
Journal: Blood
Blood (2008) 112 (3): 760–769.
https://doi.org/10.1182/blood-2008-02-142687
Published: 2008
Includes: Supplemental data
Journal Articles

Identification of Vacuolar H + - ATPase as a Target for Myeloma Therapeutics.

Yuan Xiao Zhu, PhD, Chung Xin, Shi, Ph.D., Sheng Ben Liang Lian, Ph.D., Wee-Joo Chng, M.D., Suzanne Trudel, M.D., Keith Stewart, M.D.
Journal: Blood
Blood (2007) 110 (11): 257.
https://doi.org/10.1182/blood.V110.11.257.257
Published: 2007
Journal Articles

Evaluation of XL999, a Potent Inhibitor of FGFR3, for the Potential Treatment of t(4;14) Positive Multiple Myeloma.

Suzanne Trudel, MD, Xiu Zhi Yang, MD, Zhi Hua Li, MD, Sheng-ben Liang, PhD, Dana T. Aftab, PhD
Journal: Blood
Blood (2007) 110 (11): 2515.
https://doi.org/10.1182/blood.V110.11.2515.2515
Published: 2007
Journal Articles

The inhibitory anti-FGFR3 antibody, PRO-001, is cytotoxic to t(4;14) multiple myeloma cells

Suzanne Trudel, A. Keith Stewart, Eran Rom, Ellen Wei, Zhi Hua Li, Sarit Kotzer, Irina Chumakov, Yossi Singer, Hong Chang, Sheng-Ben Liang, Avner Yayon
Journal: Blood
Blood (2006) 107 (10): 4039–4046.
https://doi.org/10.1182/blood-2005-10-4179
Published: 2006
Journal Articles

Functional Engraftment of Retrovirally Transduced and Pre-Selected Hematopoietic Cells into Partially Ablated Recipient Fabry Mice.

Jeffrey A. Medin, PhD, Sheng-Ben Liang, MD, PhD, Armando Poeppl, Makoto Yoshimitsu, MD, Jagdeep S. Walia, MBBS, Jianhui Cai, MD, PhD, Vanessa I. Rasaiah, Daniel H. Fowler, MD
Journal: Blood
Blood (2005) 106 (11): 3023.
https://doi.org/10.1182/blood.V106.11.3023.3023
Published: 2005
Journal Articles

Long-Term and Sustained Correction of the α-Galactosidase A Deficiency in Fabry Mice and Patient Cells Receiving Lentivirally Transduced Hematopoietic Stem/Progenitor Cells.

Makoto Yoshimitsu, MD, Christopher Siatskas, PhD, Sheng-Ben Liang, MD, PhD, Vanessa I. Rasaiah, Koji Higuchi, MD, Gary J. Murray, PhD, Toshihiro Takenaka, MD, PhD, Chuwa Tei, MD, PhD, Roscoe O. Brady, MD, Jeffrey A. Medin, PhD
Journal: Blood
Blood (2005) 106 (11): 1285.
https://doi.org/10.1182/blood.V106.11.1285.1285
Published: 2005